DocGo Cost Of Revenue from 2010 to 2024

DCGO Stock  USD 4.25  0.13  3.16%   
DocGo Cost Of Revenue yearly trend continues to be very stable with very little volatility. Cost Of Revenue is likely to drop to about 228.4 M. During the period from 2010 to 2024, DocGo Cost Of Revenue quarterly data regression pattern had sample variance of 16083.6 T and median of  35,109,591. View All Fundamentals
 
Cost Of Revenue  
First Reported
2010-12-31
Previous Quarter
445.3 M
Current Value
228.4 M
Quarterly Volatility
126.8 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check DocGo financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among DocGo's main balance sheet or income statement drivers, such as Tax Provision of 6.6 M, Net Interest Income of 1.8 M or Depreciation And Amortization of 9.7 M, as well as many indicators such as Price To Sales Ratio of 0.88, Dividend Yield of 0.0 or PTB Ratio of 1.83. DocGo financial statements analysis is a perfect complement when working with DocGo Valuation or Volatility modules.
  
Check out the analysis of DocGo Correlation against competitors.

Latest DocGo's Cost Of Revenue Growth Pattern

Below is the plot of the Cost Of Revenue of DocGo Inc over the last few years. Cost of Revenue is found on DocGo Inc income statement and represents the costs associated with goods and services DocGo provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities. It is DocGo's Cost Of Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in DocGo's overall financial position and show how it may be relating to other accounts over time.
Cost Of Revenue10 Years Trend
Slightly volatile
   Cost Of Revenue   
       Timeline  

DocGo Cost Of Revenue Regression Statistics

Arithmetic Mean105,486,249
Geometric Mean63,438,164
Coefficient Of Variation120.23
Mean Deviation99,534,563
Median35,109,591
Standard Deviation126,821,239
Sample Variance16083.6T
Range410.2M
R-Value0.74
Mean Square Error7932.4T
R-Squared0.54
Significance0
Slope20,877,965
Total Sum of Squares225170.8T

DocGo Cost Of Revenue History

2024228.4 M
2023445.3 M
2022285.8 M
2021209 M
202062.7 M

About DocGo Financial Statements

DocGo investors utilize fundamental indicators, such as Cost Of Revenue, to predict how DocGo Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Cost Of Revenue445.3 M228.4 M

Pair Trading with DocGo

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if DocGo position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in DocGo will appreciate offsetting losses from the drop in the long position's value.

Moving together with DocGo Stock

  0.8ENOV Enovis CorpPairCorr

Moving against DocGo Stock

  0.8FIGS Figs IncPairCorr
  0.77PHG Koninklijke PhilipsPairCorr
  0.64CVS CVS Health Corp Aggressive PushPairCorr
  0.64EVH Evolent HealthPairCorr
  0.52AGL agilon healthPairCorr
The ability to find closely correlated positions to DocGo could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace DocGo when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back DocGo - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling DocGo Inc to buy it.
The correlation of DocGo is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as DocGo moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if DocGo Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for DocGo can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether DocGo Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of DocGo's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Docgo Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Docgo Inc Stock:
Check out the analysis of DocGo Correlation against competitors.
You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of DocGo. If investors know DocGo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about DocGo listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.09
Earnings Share
0.29
Revenue Per Share
6.752
Quarterly Revenue Growth
(0.26)
Return On Assets
0.0658
The market value of DocGo Inc is measured differently than its book value, which is the value of DocGo that is recorded on the company's balance sheet. Investors also form their own opinion of DocGo's value that differs from its market value or its book value, called intrinsic value, which is DocGo's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because DocGo's market value can be influenced by many factors that don't directly affect DocGo's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between DocGo's value and its price as these two are different measures arrived at by different means. Investors typically determine if DocGo is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, DocGo's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.